Marc van Dijk

2023

In 2023, Marc van Dijk earned a total compensation of $524.8K as Chief Scientific Officer at MiNK Therapeutics, a 19% decrease compared to previous year.

Compensation breakdown

Bonus$75,000
Option Awards$26,550
Salary$333,989
Stock Awards$39,926
Other$49,294
Total$524,759

van Dijk received $334K in salary, accounting for 64% of the total pay in 2023.

van Dijk also received $75K in bonus, $26.6K in option awards, $39.9K in stock awards and $49.3K in other compensation.

Rankings

In 2023, Marc van Dijk's compensation ranked 1,892nd out of 2,785 executives tracked by ExecPay. In other words, van Dijk earned more than 32.1% of executives.

ClassificationRankingPercentile
All
1,892
out of 2,785
32nd
Division
Manufacturing
1,080
out of 1,525
29th
Major group
Chemicals And Allied Products
672
out of 864
22nd
Industry group
Drugs
655
out of 827
21st
Industry
Biological Products, Except Diagnostic Substances
174
out of 204
15th
Source: SEC filing on April 29, 2024.

van Dijk's colleagues

We found two more compensation records of executives who worked with Marc van Dijk at MiNK Therapeutics in 2023.

2023

Jennifer Buell

MiNK Therapeutics

Chief Executive Officer

2023

Christine Klaskin

MiNK Therapeutics

Treasurer

News

You may also like